Concepedia

Fu‐Fei Hsu

FH

Statistics

Publications

17

Citations

1.3K

H-Index

15

Active since

2003

Affiliations

Institute of Biomedical Sciences, Academia Sinica(Current)

National Tsing Hua University

Institute of Cellular and Organismic Biology, Academia Sinica

Academia Sinica

Chang Gung University

Fu‐Fei Hsu is an author at Institute of Biomedical Sciences, Academia Sinica specializing in nanomedicine, oncology, and pharmacy.

ORCID

Publications per year

2003–2023

17

Publications

17

Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies

Yun‐Chieh Sung, Pei-Ru Jin, Li‐An Chu et al. · Nature Nanotechnology · 2019 · 446 citations

, , +16

Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer

Kuan‐Wei Huang, Fu‐Fei Hsu, Guann-Jen Chern et al. · Science Advances · 2020 · 254 citations · Full text

, , +17

The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1

Yi-Hung Ou, Pei-Han Chung, Fu‐Fei Hsu et al. · The EMBO Journal · 2007 · 108 citations · Full text

, , +12

Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors

Yunching Chen, Ya-Chi Liu, Yun‐Chieh Sung et al. · Scientific Reports · 2017 · 86 citations · Full text

, , +17

A multifunctional nanocarrier for efficient TRAIL‐based gene therapy against hepatocellular carcinoma with desmoplasia in mice

Chun‐Hung Liu, Guann‐Jen Chern, Fu‐Fei Hsu et al. · Hepatology · 2017 · 51 citations · Full text

, , +17

1–5 of 17